查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1900590

小动物影像（体内）市场规模、份额和成长分析（按成像方式、试剂、应用、最终用户和地区划分）－2026-2033年产业预测

Small Animal Imaging In Vivo Market Size, Share, and Growth Analysis, By Modality (Optical Imaging Systems, Nuclear Imaging Systems), By Reagents, By Application, By End-User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 224 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球小动物体内影像市场规模预计在 2024 年达到 11.5 亿美元，从 2025 年的 12.4 亿美元成长到 2033 年的 22.7 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.8%。

随着微型磁振造影（micro-MRI）、微型电脑断层扫描（micro-CT）和微型正子断层扫描（micro-PET）等各种核子医学成像技术发展成为先进的微型仪器，全球小型动物影像市场正经历显着的进步。多模态成像技术（包括微型超音波和光学成像）的发展，以及临床前研究的增加和受託研究机构（CRO）投资的成长，都推动了这一趋势。然而，严格的监管要求和不完善的报销机制等挑战可能会阻碍市场扩张。儘管有这些限制，但价格较亲民的技术的出现有望推动市场成长，尤其是在新兴市场。北美凭藉其先进的技术应用和有利的政策，在该领域处于领先地位，而亚太地区正在迅速崛起，为小动物成像领域的公司提供了巨大的机会。

推动全球小动物体内影像市场发展的因素

全球小型动物生物成像市场预计将迎来显着成长，主要驱动力在于多模态成像技术的日益普及。这些先进的成像解决方案因其能够提供对生物过程的全面洞察而备受关注。此外，医疗保健领域预算的增加也推动了对专用于小型动物的尖端成像设备的投资，从而增强了研究能力并加速了兽医学的发展。技术创新和资金支持的共同作用预计将为小型动物成像市场在不久的将来蓬勃发展创造有利环境。

限制全球小动物影像与体内市场发展的因素

全球小型动物生物成像市场面临许多挑战，可能阻碍其扩张。高昂的设备成本和技术限制构成了市场准入和发展的巨大障碍。此外，开发中国家熟练专业人员的短缺进一步加剧了这一局面。加之研究设施和基础设施的匮乏，这些因素共同限制了市场的潜在成长。随着该领域的不断进步，应对这些挑战对于确保研究人员和机构拥有更强大、更便利的小型动物影像环境至关重要。若缺乏策略性解决方案，市场可能难以在这些限制条件下充分发挥其潜力。

全球小动物影像与体内市场趋势

全球小型动物体内影像市场正经历显着成长，这主要得益于研究人员和製药公司对非侵入性成像技术日益增长的需求。公共和私人机构不断增加的资金投入也为这一快速增长提供了支持，推动了化学、电脑科学、工程和分子生物学等多个领域的进步。此外，研究机构的扩张及其对创新技术的关注也推动了市场的动态。新兴经济体正在创造新的成长机会，加之对倡议的高度重视，预计小型动物影像市场将持续维持成长动能。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 技术进步
  • 监管环境

全球小动物影像（体内）市场规模（按成像方式和复合年增长率划分）（2026-2033 年）

  • 光学成像系统
    • 生物发光成像
    • 萤光影像
  • 核子医学扫描术诊断系统
    • 正子断层扫描（PET）
    • 单光子发射电脑断层扫描（SPECT）
  • 磁振造影（MRI）系统
  • 电脑断层扫描（CT）系统
  • 超音波成像系统
  • 光声成像系统

全球小动物成像（体内）市场规模（按试剂和复合年增长率划分）（2026-2033 年）

  • 光学成像试剂
  • 核子医学影像试剂
  • 磁振造影剂
  • 超音波造影剂
  • CT造影剂

全球小动物影像（体内）市场规模（按应用及复合年增长率划分）（2026-2033 年）

  • 生物分布研究
  • 癌细胞检测
  • 生物标誌物
  • 纵贯研究
  • 药物研发
  • 功能和解剖成像

全球小型动物影像（体内）市场规模（以最终用户划分）及复合年增长率（2026-2033 年）

  • 製药和生物技术公司
  • 学术研究机构
  • 合约研究组织（CRO）
  • 医院和诊所

全球小动物影像（体内）市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Bruker Corporation（US）
  • PerkinElmer, Inc.（US）
  • FUJIFILM Holdings Corporation（Japan）
  • Siemens Healthineers AG（Germany）
  • Miltenyi Biotec（Germany）
  • Aspect Imaging（Israel）
  • Thermo Fisher Scientific Inc.（US）
  • GE Healthcare（US）
  • Mediso Ltd.（Hungary）
  • MR Solutions Ltd.（UK）
  • TriFoil Imaging（US）
  • Key Developments
  • Agilent Technologies, Inc.（US）
  • Hitachi Ltd.（Japan）
  • Canon Medical Systems Corporation（Japan）

结论与建议

简介目录
Product Code: SQSG35A2089

Global Small Animal Imaging In Vivo Market size was valued at USD 1.15 Billion in 2024 and is poised to grow from USD 1.24 Billion in 2025 to USD 2.27 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global small animal imaging market is witnessing significant advancements, driven by various nuclear imaging technologies like micro MRI, micro CT, and micro PET, which have evolved into sophisticated micro-level equipment. Growth in multimodal imaging, including micro-ultrasound and optical imaging, coupled with increased pre-clinical research and investments from contract research organizations (CROs), supports this trend. However, challenges such as stringent regulatory requirements and inadequate reimbursement scenarios could hinder expansion. Despite these limitations, the rise of affordable technologies is anticipated to promote growth, especially in emerging markets. North America leads this sector due to its advanced technology adoption and favorable policies, but the Asia-Pacific region is emerging rapidly, representing substantial opportunities for companies in the small animal imaging field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Animal Imaging In Vivo Market Segments Analysis

Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Animal Imaging In Vivo Market

The market for global small animal imaging in vivo is poised for significant growth, largely driven by the increasing adoption of multimodal imaging technologies. These advanced imaging solutions are gaining traction due to their ability to provide comprehensive insights into biological processes. Furthermore, the healthcare sector's expanding budgets are facilitating investments in cutting-edge imaging equipment tailored for small animals, thereby enhancing research capabilities and accelerating advancements in veterinary medicine. This interplay of technological innovation and financial commitment is expected to create a favorable environment for the flourishing of the small animal imaging market in the foreseeable future.

Restraints in the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market faces several challenges that could hinder its expansion. High equipment costs and technological constraints pose significant barriers to entry and progress. Additionally, the shortage of skilled professionals in developing countries further exacerbates the situation. Coupled with insufficient research facilities and infrastructure, these factors collectively limit the market's potential growth. As advancements continue in this field, addressing these issues will be crucial to ensuring a more robust and accessible small animal imaging environment for researchers and institutions. Without strategic solutions, the market may struggle to realize its full potential amidst these constraints.

Market Trends of the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by an increasing demand for non-invasive imaging techniques among researchers and pharmaceutical companies. This surge is supported by enhanced funding from public and private organizations, fostering advancements across various disciplines such as chemistry, computer science, engineering, and molecular biology. Moreover, the expansion of research organizations and a focus on innovative technologies are propelling market dynamics. Emerging economies are likewise contributing to new growth opportunities, coupled with a strong emphasis on research and development initiatives, positioning the small animal imaging market for continued momentum and advancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Small Animal Imaging In Vivo Market Size by Modality & CAGR (2026-2033)

  • Market Overview
  • Optical Imaging Systems
    • Bioluminescence Imaging
    • Fluorescence Imaging
  • Nuclear Imaging Systems
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
  • Magnetic Resonance Imaging (MRI) Systems
  • Computed Tomography (CT) Systems
  • Ultrasound Imaging Systems
  • Photoacoustic Imaging Systems

Global Small Animal Imaging In Vivo Market Size by Reagents & CAGR (2026-2033)

  • Market Overview
  • Optical Imaging Reagents
  • Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

Global Small Animal Imaging In Vivo Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Biodistribution Studies
  • Cancer Cell Detection
  • Biomarkers
  • Longitudinal Studies
  • Drug Development
  • Functional and Anatomical Imaging

Global Small Animal Imaging In Vivo Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics

Global Small Animal Imaging In Vivo Market Size & CAGR (2026-2033)

  • North America (Modality, Reagents, Application, End-User)
    • US
    • Canada
  • Europe (Modality, Reagents, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Modality, Reagents, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Modality, Reagents, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Modality, Reagents, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspect Imaging (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediso Ltd. (Hungary)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR Solutions Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TriFoil Imaging (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
  • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations